Indian Journal of Medical and Paediatric Oncology
References
Du Bois A, Floquet A, Kim J. et al.
Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (AEOC): results of an international intergroup trial (AGO-OVAR16).
J Clin Oncol 2013;
31 (Suppl. 18) LBA5503-LBA5503
Du Bois A, Floquet A, Kim J. et al.
Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (AEOC): results of an international intergroup trial (AGO-OVAR16).
J Clin Oncol 2013;
31 (Suppl. 18) LBA5503-LBA5503
We do not assume any responsibility for the contents of the web pages of other providers.